60 peer-reviewed studies · Evidence score: 9/10
Cheng YC et al. • Psychological medicine (2025)
This extensive systematic review and NMA of nutraceuticals for treating depressive disorders indicated a number of nutraceuticals that could offer benefits, either as adjuncts or monotherapies.
Urata M et al. • Neuropsychopharmacology reports (2025)
This review demonstrates that certain supplements, such as eicosapentaenoic acids and Rhodiola rosea, are therapeutic options for mild depression.
Lafontant K et al. • Journal of the International Society of Sports Nutrition (2025)
While there are no differences in percent body fat loss between exercise modes, AT and CT are more effective than RT alone in reducing absolute fat mass; however, RT neither improved nor impeded fat mass loss when incorporated into CT.
Romoli M et al. • Neurology (2025)
Keeping the same DOAC and switching to another DOAC, independently from mechanism, had similar rates of primary and secondary outcomes.
Furukawa Y et al. • BMJ open (2023)
Shorter treatment duration (3-5 days) probably offers the optimal balance between efficacy and treatment burden for treating CAP in adults if they achieved clinical stability.
Lee B et al. • JAMA network open (2023)
In this NMA, sham acupuncture needling at the same points as those in acupuncture was not a true placebo control for assessing the efficacy of acupuncture for CLBP and might underestimate the outcome of acupuncture in clinical settings.
Werneck AO et al. • Clinical nutrition (Edinburgh, Scotland) (2024)
A higher adherence to the ultra-processed dietary pattern was associated with a higher risk of developing depressive outcomes in the NutriNet Brasil cohort and in the meta-analysis.
Beaudart C et al. • Aging clinical and experimental research (2023)
Medications used in the management of osteoporosis in women appear to provide similar benefits in men with osteoporosis.
Zhao Y et al. • Journal of Alzheimer's disease : JAD (2023)
SAM supplementation showed no significant improvement in cognition.
Lan J et al. • Journal of ethnopharmacology (2015)
This study indicates that berberine has comparable therapeutic effect on type 2 DM, hyperlipidemia and hypertension with no serious side effect.
Walker KF et al. • The Cochrane database of systematic reviews (2020)
When compared with placebo, UDCA administered to women with ICP probably shows a reduction in pruritus.
Jung YS et al. • Gastrointestinal endoscopy (2020)
Among the HRA and LRA groups, those with diminutive NAAs had a lower risk of metachronous ACRN than those with small NAAs.
Galizia I et al. • Journal of Psychopharmacology (2016)
SAMe was superior to placebo and comparable to antidepressants.
Cruz S et al. • Neuropsychology review (2025)
This meta-analysis examined the effects of SAMe.
Berry-Noronha A et al. • Neurology (2025)
The odds of small-for-gestational age differed across ASMs, with signals pointing to an association with clonazepam, oxcarbazepine, topiramate, and zonisamide.
French JMR et al. • The bone & joint journal (2024)
Within the limitations of the literature, in particular the substantial risk of selection bias, the outcomes following day-case knee and hip replacement appear not to be inferior to those following an inpatient stay.
Limveeraprajak N et al. • Progress in neuro-psychopharmacology & biological psychiatry (2024)
Moderate-certainty evidence suggests that SAMe monotherapy may offer a moderate therapeutic benefit in alleviating depressive symptoms.
Tan MY et al. • Frontiers in public health (2023)
The results showed that CAM therapies were able to alleviate NVP.
Van Swol JM et al. • Orbit (Amsterdam, Netherlands) (2023)
Regarding success of re-operation, surgeons can use the method they are most comfortable with to perform DCR revisions.
Nethan ST et al. • Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco (2020)
Behavioral interventions as a single modality are effective in SLT cessation, both in the developed and developing countries.